|
In a shot of bad news to sex lovers, the US FDA gave an initial "sorry, dear" to the regulatory approval of bremelanotide for erectile dysfunction. Bremelanotide acts on the melanocortin receptors of the brain. Previous research showed that bremelanotide can increase sexual arousal and might be of use for treating various types of sexual dysfunction. There is particular hopes that this chemical might be the female equivalent of viagra.
The FDA said it was particularly concerned with the possibility that bremelanotide might raise blood pressure in some men. It isn't clear if this will affect the approval process for women, which is on a separate track.
|
read more
Filed under Aphrodisiacs by Eros
